Home/Filings/4/0001209191-09-004186
4//SEC Filing

SPRINGFIELD CLAUDE H III 4

Accession 0001209191-09-004186

CIK 0000715072other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:42 PM ET

Size

21.6 KB

Accession

0001209191-09-004186

Insider Transaction Report

Form 4
Period: 2009-01-16
SPRINGFIELD CLAUDE H III
Sr. Executive Vice President
Transactions
  • Award

    Stock Option (Right to Buy)

    2009-01-16$17.03/sh+7,500$127,7257,500 total
    Exercise: $17.03Exp: 2019-01-01Common (7,500 underlying)
  • Award

    Common Stock (Restricted)

    2009-01-16$17.63/sh1,500$26,4450 total
  • Award

    Common Stock (Restricted)

    2009-01-16$17.03/sh+1,500$25,5451,500 total
Holdings
  • Common Stock

    27,328
  • Common Stock

    944.409
  • Common Stock

    8,704.39
  • Stock Option (Right to Buy)

    Exercise: $17.63Exp: 2018-01-01Common (7,500 underlying)
    7,500
  • Stock Option (Right to Buy)

    Exercise: $30.63Exp: 2017-01-01Common (7,500 underlying)
    7,500
  • Stock Option (Right to Buy)

    Exercise: $21.93From: 2009-01-01Exp: 2016-01-01Common (7,500 underlying)
    7,500
  • Stock Option (Right to Buy)

    Exercise: $22.23From: 2007-01-01Exp: 2014-01-01Common (7,875 underlying)
    7,875
  • Stock Option (Right to Buy)

    Exercise: $18.77From: 2006-01-01Exp: 2013-01-01Common (7,875 underlying)
    7,875
  • Stock Option (Right to Buy)

    Exercise: $15.64From: 2005-01-01Exp: 2012-01-01Common (7,875 underlying)
    7,875
  • Phantom Stock

    Common (2,816.53 underlying)
    2,893.2
  • Stock Option (Right to Buy)

    Exercise: $22.77From: 2008-01-01Exp: 2015-01-01Common (7,875 underlying)
    7,875
Footnotes (4)
  • [F1]This is the adjustment to the target amount of the 2008 performance based restricted stock previously reported.
  • [F2]This is the target amount of a performance based restricted stock grant available if certain criteria is met. Any adjustments to the target award will be reported at the time of the actual determination of performance as compared to the applicable threshold, target and maxium performance objectives. In no event, however, will the number of shares awarded exceed 150% of the number of shares of the target award. The share price will be determined at the close of business on the end of the performance cycle.
  • [F3]Beginning with the issue date, equal installments of 33 1/3 of the option shares granted will be available for exercise upon completion of one, two and three years of service measured from date of grant, respectively. The options expire ten (10) years from the grant date.
  • [F4]The phantom stock units are accrued under the Renasant DSU Plan. The units are settled 100% in the Company's common stock upon the reporting person's retirement or upon approved hardship reasons. The conversion price is one phantom stock unit for one share of the Company's common stock. Dividends are paid quarterly and reinvested on the phantom stock.

Issuer

RENASANT CORP

CIK 0000715072

Entity typeother

Related Parties

1
  • filerCIK 0001192030

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:42 PM ET
Size
21.6 KB